Pharma Mega-Mergers, Rise and Shein 1/9/24

from Power Lunch · host CNBC

Pharmaceutical giants are shelling out billions of dollars lately to buy promising new drugs. Is this a sign of good financial health, or a problem with pipelines? We’ll discuss.Plus, there’s more and more data coming out on Shein as it prepares for a U.S. IPO. We’ll break down it’s revenue numbers, and where it ranks compared to American retailers. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Episode metadata supplied by the publisher feed · Published Jan 9, 2024

Embed this episode

Attribution link and audio player

What this episode covers

Pharmaceutical giants are shelling out billions of dollars lately to buy promising new drugs. Is this a sign of good financial health, or a problem with pipelines? We’ll discuss. Plus, there’s more and more data coming out on Shein as it prepares for a U.S. IPO. We’ll break down it’s revenue numbers, and where it ranks compared to American retailers.

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Pharma Mega-Mergers, Rise and Shein 1/9/24

0:00 43:56

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Power Lunch?

This episode is 43 minutes long.

When was this Power Lunch episode published?

This episode was published on January 9, 2024.

Can I download this Power Lunch episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!